mk2 Biotechnologies
Loading ...
- Chemicals/Pharmaceuticals
- Startup Stage
- Manufacturing
- B2B
- 2017
-
1-10 Employees
- Found
- Planegg, DE
- Login required
- mk2 Biotechnologies GmbH
-
Bayern
Profile is not claimed et
This profile is created by the Startbase Analyst Team. If you are a team member of this company you can claim the profile in order to make changes to it.
Is this your company?
Claim profile
About the Team
Are you part of this team?
Byron Konstantinos Antonopoulos
Geschäftsführer
Sebastian Mangold
Geschäftsführer
Marco Massimiliano Giuman
Geschäftsführer
News about mk2 Biotechnologies
Latest feature of mk2 Biotechnologies:
Mk2 Biotechnologies, Wacker und TUM kooperieren
Das Konsortium der drei Unternehmen möchte in einem gemeinsamen Projekt Wege finden, antimikrobielle Peptide kosteneffizient herzustellen. Sie eignen sich zum Beispiel als natürliches Konservierungsmittel.
09.06.2022
Recent mentions of mk2 Biotechnologies in podcasts & videos:
Jobs at mk2 Biotechnologies:
Related companies
Investor
2005
Bonn
High-Tech Gründerfonds
HTGF is one of the leading and most active early-stage investors in Germany and Europe.
Investor
Wien
Speedinvest
More expertise, connections, and momentum. From Seed to Growth in Europe & beyond. Unlock: The Power of More.
Startup
2019
Planegg
Tubulis
Reimagining
Antibody Drug Conjugates
Protein-drug conjugates by combining proprietary novel technologies with disease-specific biology.
Startup
2016
Gräfelfing
Immunic Therapeutics
Clinical-stage biopharmaceutical company developing a range of selective oral immunological therapies.
Startup
2017
Freising
4GENE
Natural, biotechnologically produced, activatable small molecules marketed as flavor-on-demand to cosmetic and pharmaceutical companies and industrial customers worldwide.
Other Startups nearby
Startup
2010
Planegg
Lindis Biotech
Development of Triomab® antibodies - a new class of T-cell activating bispecific antibodies that enable the immune system to transform malignant cancers into treatable and potentially curable diseases.
Startup
2013
Planegg
Bind-X
Industrial applications in the field of biotechnology.
Startup
2016
Planegg
SciRhom
Developing drugs to combat life-threatening diseases.
Startup
2016
Planegg
PreOmics
Develops and provides technologies for mass spectrometry-based proteomics.
Startup
2015
Planegg
Atriva Therapeutics
Antiviral therapies against several severe respiratory viral infections with high unmet medical need, such as influenza and COVID-19.
FYI: English edition available
Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?
FYI: Deutsche Edition verfügbar
Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?